TrialCurrent oncology (Toronto, Ont.)2025

Phase Ib/II Study of Pamiparib Plus Radiation Therapy and/or Temozolomide in Adult Patients with Treatment-Naïve or Recurrent/Refractory Glioblastoma.

Anna F Piotrowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.